171 related articles for article (PubMed ID: 32595377)
1. Neonatal Diabetes Mellitus.
Zübarioğlu AU; Bülbül A; Uslu HS
Sisli Etfal Hastan Tip Bul; 2018; 52(2):71-78. PubMed ID: 32595377
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
Flechtner I; de Lonlay P; Polak M
Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
[TBL] [Abstract][Full Text] [Related]
4. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus.
Loomba-Albrecht LA; Glaser NS; Styne DM; Bremer AA
Clin Ther; 2009 Apr; 31(4):816-20. PubMed ID: 19446154
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
Gloyn AL; Pearson ER; Antcliff JF; Proks P; Bruining GJ; Slingerland AS; Howard N; Srinivasan S; Silva JM; Molnes J; Edghill EL; Frayling TM; Temple IK; Mackay D; Shield JP; Sumnik Z; van Rhijn A; Wales JK; Clark P; Gorman S; Aisenberg J; Ellard S; Njølstad PR; Ashcroft FM; Hattersley AT
N Engl J Med; 2004 Apr; 350(18):1838-49. PubMed ID: 15115830
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Neonatal Diabetes.
Dahl A; Kumar S
Diabetes Metab Syndr Obes; 2020; 13():355-364. PubMed ID: 32104032
[TBL] [Abstract][Full Text] [Related]
7. Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation.
Ahn SY; Kim GH; Yoo HW
Korean J Pediatr; 2015 Aug; 58(8):309-12. PubMed ID: 26388896
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected].
Busiah K; Drunat S; Vaivre-Douret L; Bonnefond A; Simon A; Flechtner I; Gérard B; Pouvreau N; Elie C; Nimri R; De Vries L; Tubiana-Rufi N; Metz C; Bertrand AM; Nivot-Adamiak S; de Kerdanet M; Stuckens C; Jennane F; Souchon PF; Le Tallec C; Désirée C; Pereira S; Dechaume A; Robert JJ; Phillip M; Scharfmann R; Czernichow P; Froguel P; Vaxillaire M; Polak M; Cavé H;
Lancet Diabetes Endocrinol; 2013 Nov; 1(3):199-207. PubMed ID: 24622368
[TBL] [Abstract][Full Text] [Related]
9. Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11.
Yoon JS; Park KJ; Sohn YB; Lee HS; Hwang JS
Ann Pediatr Endocrinol Metab; 2018 Sep; 23(3):154-157. PubMed ID: 30286572
[TBL] [Abstract][Full Text] [Related]
10. Permanent neonatal diabetes mellitus due to a C96Y heterozygous mutation in the insulin gene. A case report.
Ahamed A; Unnikrishnan AG; Pendsey SS; Nampoothiri S; Bhavani N; Praveen VP; Kumar H; Jayakumar RV; Nair V; Ellard S; Edghill EL
JOP; 2008 Nov; 9(6):715-8. PubMed ID: 18981553
[TBL] [Abstract][Full Text] [Related]
11. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
Bremer AA; Ranadive S; Lustig RH
Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
[TBL] [Abstract][Full Text] [Related]
12. Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene.
Al-Mahdi M; Al Mutair A; Al Balwi M; Hussain K
Ann Saudi Med; 2010; 30(2):162-4. PubMed ID: 20220270
[TBL] [Abstract][Full Text] [Related]
13. The genetic basis of neonatal diabetes mellitus.
Sperling MA
Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():71-5. PubMed ID: 17261973
[TBL] [Abstract][Full Text] [Related]
14. Continuous Glucose Monitoring in Transient Neonatal Diabetes Mellitus-2 Case Reports and Literature Review.
Chisnoiu T; Balasa AL; Mihai L; Lupu A; Frecus CE; Ion I; Andrusca A; Pantazi AC; Nicolae M; Lupu VV; Ionescu C; Mihai CM; Cambrea SC
Diagnostics (Basel); 2023 Jul; 13(13):. PubMed ID: 37443665
[TBL] [Abstract][Full Text] [Related]
15. Overview of neonatal diabetes.
Hamilton-Shield JP
Endocr Dev; 2007; 12():12-23. PubMed ID: 17923765
[TBL] [Abstract][Full Text] [Related]
16. Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.
Zung A; Glaser B; Nimri R; Zadik Z
J Clin Endocrinol Metab; 2004 Nov; 89(11):5504-7. PubMed ID: 15531505
[TBL] [Abstract][Full Text] [Related]
17. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
[TBL] [Abstract][Full Text] [Related]
18. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
[TBL] [Abstract][Full Text] [Related]
19. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy.
Hattersley AT; Ashcroft FM
Diabetes; 2005 Sep; 54(9):2503-13. PubMed ID: 16123337
[TBL] [Abstract][Full Text] [Related]
20. Diabetes in very young children and mutations in the insulin-secreting cell potassium channel genes: therapeutic consequences.
Flechtner I; Vaxillaire M; Cavé H; Scharfmann R; Froguel P; Polak M
Endocr Dev; 2007; 12():86-98. PubMed ID: 17923772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
